Hengrui and Kailera have been vocal about positioning the drug as being capable of improving the clinical profile of existing ...

It’s exciting news in an orphan indication which currently lacks any approved treatment, and Dr Hans Lee, director of ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

The EU is asking for feedback on measures proposed by Sanofi to address concerns about a marketing campaign for a flu vaccine ...

In another big-ticket licensing deal with a Chinese biotech, AstraZeneca has claimed rights to a drug candidate for chronic ...

Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026, at Park Hyatt Aviara Resort, Golf Club & Spa ...

Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been recommended for conditional approval in the EU. The EMA's human medicines ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

As practising oncologists, we've seen firsthand how a cancer diagnosis changes the way patients engage with information.

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...